$DOW · DOW INC.
Dow filed its Q3 FY2026 Form 10-Q for the quarter ended September 30, 2026. Net sales rose 13.0% year over year to $11.267B, operating segment EBIT was $915M versus $232M, and net income available to common stockholders was $458M versus $62M. Nine-month net income available to common stockholders was $646M versus a loss of $1,080M.
- Q3 diluted EPS was $0.62 versus $0.08 in the prior-year quarter.
- Operating segment EBIT was $915M, up from $232M a year earlier.
- Q3 restructuring and asset-related charges-net were $9M, down from $23M.
- Nine-month capital expenditures were $1,841M versus $1,911M.
- Cash and cash equivalents ended at $4,142M versus $3,816M at December 31, 2025.
Extended-hours last trade $32.10, up 0.91% versus the $31.81 regular close, adding to a 4.71% regular-session gain on the earnings release.
Dow's Q3 swing to $458M common-stock net income from $62M signals accelerating earnings recovery in the chemicals cycle.
Packaging & Specialty Plastics net sales rose to $5,778M from $4,891M, lifting its segment operating EBIT to $585M from $199M.
Dow flags the completion and success of its integrated ethylene cracker and derivatives facility in Alberta, Canada as a key operational risk. Sanctions, export restrictions, and Russia/Ukraine and Middle East conflict uncertainties are also cited.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.